IR Biosciences Holdings Stock (OTC: IRBS)

Latest news for IR Biosciences Holdings (OTC:IRBS) Stock

IR Biosciences Holdings Inc is a development-stage biotechnology company engaged in the research & development of potential drug candidate, Homspera and its derivatives, Radilex and Viprovex through its subsidiary, ImmuneRegen BioSciences, Inc. It is engaged in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia.

IR BIOSCIENCES HLDGS INC by IR Biosciences Holdings, Inc.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

IR Biosciences Holdings

News

Latest news for IR Biosciences Holdings (OTC:IRBS) Stock